New Perspectives in Cyclodextrin Pharmaceutical Applications Kaneto UekamaTetsumi Irie Short Communication 26 October 2012 Pages: 22 - 28
Biopharmaceutical Optimisation of β-Cyclodextrin Inclusion Compounds D. AcerbiG. BovisT. Peveri OriginalPaper 26 October 2012 Pages: 29 - 36
Toxicological Profile of Piroxicam-β-Cyclodextrin S. CadelS. Bongrani OriginalPaper 26 October 2012 Pages: 37 - 41
Pharmacokinetic Profile of Piroxicam-β-Cyclodextrin D. Acerbi OriginalPaper 26 October 2012 Pages: 42 - 49
Rapid Oral Absorption Profile of Piroxicam from its β-Cyclodextrin Complex D. AcerbiE. Lebacq JrP. Ventura OriginalPaper 26 October 2012 Pages: 50 - 55
Gastric Tolerance of Piroxicam-β-Cyclodextrin Compared with Placebo and with Other NSAIDs L. SantucciS. FiorucciA. Morelli OriginalPaper 26 October 2012 Pages: 56 - 60
Review of the Analgesic Effects of Piroxicam-β-Cyclodextrin M. Tiengo OriginalPaper 26 October 2012 Pages: 61 - 66
Piroxicam-β-Cyclodextrin in Sports Medicine and Traumatology V. WyssG. P. Ganzit OriginalPaper 26 October 2012 Pages: 67 - 72
Piroxicam-β-Cyclodextrin in the Treatment of Dysmenorrhoea S. CostaG. ZinelliL. Bufalino OriginalPaper 26 October 2012 Pages: 73 - 78
Piroxicam-β-Cyclodextrin in the Treatment of Headache G. NappiG. C. ManzoniC. Oliani OriginalPaper 26 October 2012 Pages: 79 - 85